Grifols
GRFS
$6.58
Share price
-2.95%
Change (1 day)
-13.53%
Change (1 year)
Categories
Grifols (GRFS) - Cash on Hand
Cash on Hand as of September 2023 : $0.57 B
According to Grifols's latest financial reports the company has $0.57 B in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
Grifols - Cash on Hand chart (from 2010 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2022-12-31 | $0.61 B | -79.59% |
| 2021-12-31 | $3.03 B | 318.09% |
| 2020-12-31 | $0.72 B | -73.74% |
| 2019-12-31 | $2.76 B | 122.3% |
| 2018-12-31 | $1.24 B | 16.92% |
| 2017-12-31 | $1.06 B | 12.96% |
| 2016-12-31 | $0.94 B | -24.58% |
| 2015-12-31 | $1.24 B | -4.82% |
| 2014-12-31 | $1.31 B | 34.09% |
| 2013-12-31 | $0.97 B | 56.34% |
| 2012-12-31 | $0.62 B | 37.56% |
| 2011-12-31 | $0.45 B | 35.47% |
| 2010-12-31 | $0.33 B | -8.96% |
| 2009-12-31 | $0.36 B | 1926.75% |
| 2008-12-31 | $18.2 M | -2.34% |
| 2007-12-31 | $18.64 M | -57.41% |
| 2006-12-31 | $43.77 M | 57.52% |
| 2005-12-31 | $27.78 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | $22.92 B | 3,891.72% | 🇺🇸 USA |
 Amgen AMGN | $10.94 B | 1,805.41% | 🇺🇸 USA |
 Baxter BAX | $3.19 B | 456.09% | 🇺🇸 USA |
 Kimberly-Clark KMB | $1.09 B | 90.30% | 🇺🇸 USA |